The pharmaceutical executive Martin Shkreli made headlines this summer when he raised the price of a generic drug by over 5,000 percent. Led by Clay Wiske MD ’16, a team of researchers presented ...
Rising prescription costs and pharmacy closures are making it harder for many Americans to afford and access their ...
A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback